Insight

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Insight

Yuki Nishida: This is one of the continuous efforts to overcome therapy resistance in acute myeloid leukemia by enhancing the activity of p53

Photo taken from Yuki Nishida/LinkedIn

Dec 7, 2023, 04:32

Yuki Nishida: This is one of the continuous efforts to overcome therapy resistance in acute myeloid leukemia by enhancing the activity of p53

Yuki Nishida, Instructor at MD Anderson Cancer Center, recently shared on LinkedIn:

“Our paper has just been published today! This is one of the continuous efforts to overcome therapy resistance in acute myeloid leukemia by enhancing the activity of p53. Thanks, Dr. Andreeff for guiding, and everyone who greatly helped this project!”

For the article click here.
Source: Yuki Nishida/LinkedIn

Acute Myeloid Leukemia cancer OncoDaily Oncology p53 Research Yuki Nishida

Jul 4, 2024, 03:53

Sarah Waliany: Reviewing the TRUST-1 trial investigating taletrectinib

Jul 4, 2024, 03:49

David Fajgenbaum: What is a cause that you’re passionate about that people give a 1 in a million chance?

Jul 4, 2024, 03:46

Why partnerships between scientists and study participants are so crucial for cancer research - NCI DCCPS

Jul 4, 2024, 03:44

Ludovica Marando: Great year working with inspiring health care professionals at Mayo Clinic Comprehensive Cancer Center

Jul 4, 2024, 03:33

Zainab Shinkafi-Bagudu: Had the privilege of delivering a masterclass on Holistic Paediatric Care at Miva Open University, Abuja

Jul 4, 2024, 03:24

Peter Obersheimer has been named to the list of Top 10 30-Somethings by the Association of Corporate Counsel

Jul 4, 2024, 03:22

Updates from Upstate NY Cancer Symposium by Oncology Brothers

Jul 4, 2024, 03:18

During Cancer Immunotherapy Month, CRI unlocked their $300,000 match

Jul 4, 2024, 03:09

C. Ola Landgren: Highlights in Multiple Myeloma From ASCO and EHA 2024

Jul 4, 2024, 01:37

Enrique Soto: What a great MASCC24 meeting

Jul 4, 2024, 01:30

ESMOIO24: Call for abstracts

Jul 4, 2024, 01:10

Matthew Cortese: Great talk by Jens Hillengass on frontline Multiple Myeloma treatment at the Upstate New York Cancer Symposium